Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.65
Delayed Data
As of Apr 20
 +0.02 / +0.55%
Today’s Change
2.58
Today|||52-Week Range
5.66
+26.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.0066.1M15.0M0.00
 
 
 
Depreciation And Amortization489.0K694.0K955.0K1.1M
 
 
 
 
 
 
Operating ExpensesGross Income-489.0K-----1.1M
 
 
 
General Expenses69.6M81.2M79.3M88.3M
 
 
 
 
 
Research And Development54.2M57.2M59.6M64.9M
 
 
 
 
 
Total Operating Expenses70.1M81.9M80.3M89.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-70.1M-15.7M-65.3M-89.4M
 
 
 
 
 
Extraordinary Credit--8.9M0.000.00
 
 
Interest Expense On Debt37.0K55.0K68.0K50.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-69.7M-5.7M-62.1M-85.1M
 
 
 
 
 
Income Taxes-678.0K-640.0K-411.0K-135.0K
 
 
 
 
 
Net Income-69.0M-5.0M-61.7M-85.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS98.4M125.6M136.7M137.2M
 
 
 
 
 
Shares To Calculate EPS Diluted98.4M125.6M136.7M137.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.70-$0.04-$0.45-$0.62
 
 
 
 
 
EPS Diluted-$0.70-$0.04-$0.45-$0.62